The number of biotechnology companies operating in New Jersey has increased in the past two years from more than 300 in 2010 to more than 340 companies in 2012, an increase of more than 13 percent, and the number of employees has increased from approximately 15,000 in 2010 to an estimated 16,400 today, an increase of 9.3 percent, according to the results of an industry survey conducted by BioNJ, the trade association for the biotechnology industry in New Jersey, and Ernst &Young. Read more »
The number of employees working at New Jersey biotechnology companies increased by 50 percent in the last three years, growing from 10,000 employees in 2007 to an estimated 15,000 in 2010, according to the results of an industry survey conducted by BioNJ, the trade association for the biotechnology industry in New Jersey, and Ernst &Young. Read more »
New Jersey’s biotechnology industry continued to both grow and mature from 2005 to 2007, according to the latest BioNJ industry survey. The industry expanded as measured by several important factors, with the number of public and private companies located in the State increasing beyond 2005 levels, while public companies experienced growth in the number of employees, revenues, research and development expenditures and market cap, according the survey released on June 30, 2008, by BioNJ with assistance from Ernst & Young.
We are pleased to share with you the results of the Biotechnology Council of New Jersey’s (BCNJ) 2006 Economic Impact Study. The contributions of our growing biotechnology industry continue to have an increasingly significant positive impact on the State of New Jersey’s economy.